SUNRISE, Fla., Sept. 22, 2011 (GLOBE NEWSWIRE) -- Bioheart, Inc. (OTCBB:BHRT) today announced it was one of the presenters at the Cell Therapy Commercialization Summit in Boston along with Genzyme, Genentech, Geron and others. Bioheart was also selected as one of only eight cell therapy companies to participate in the Cell Therapy Investor Forum.
